Literature DB >> 16461779

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment.

Maurie Markman1, Joan L Walker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461779     DOI: 10.1200/JCO.2005.05.2456

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  46 in total

1.  Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.

Authors:  Sara Previdi; Anastasia Malek; Veronica Albertini; Cristina Riva; Carlo Capella; Massimo Broggini; Giuseppina M Carbone; Jurgen Rohr; Carlo V Catapano
Journal:  Gynecol Oncol       Date:  2010-05-08       Impact factor: 5.482

Review 2.  Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.

Authors:  Antonio González-Martín; Gemma Toledo; Luis Chiva
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

3.  Office-based intraperitoneal chemotherapy for ovarian cancer.

Authors:  William R Robinson; Cathy Coberly; Julie Beyer; April Lewis; Carrie Ballard
Journal:  J Oncol Pract       Date:  2008-09       Impact factor: 3.840

4.  Treatment guidelines in ovarian cancer.

Authors:  A Poveda Velasco; A Casado Herráez; A Cervantes Ruipérez; D Gallardo Rincón; E García García; A González Martín; G López García; C Mendiola Fernández; B Ojeda González
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

5.  Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer: a new standard in patient care?

Authors:  A González Martín
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

6.  Ovarian cancer survival: steady improvement, despite rhetoric to the contrary.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

7.  Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants.

Authors:  Smrithi Padmakumar; Neha N Parayath; Shantikumar V Nair; Deepthy Menon; Mansoor M Amiji
Journal:  J Control Release       Date:  2019-05-17       Impact factor: 9.776

Review 8.  Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

Authors:  Daisuke Kobayashi; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2016-11-01       Impact factor: 7.370

9.  Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.

Authors:  Ze Lu; Max Tsai; Dan Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Pharmacol Exp Ther       Date:  2008-09-09       Impact factor: 4.030

10.  Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer.

Authors:  Emmanuel Guardiola; Delphine Delroeux; Bruno Heyd; Marielle Combe; Veronique Lorgis; Martin Demarchi; Ulrich Stein; Bernard Royer; Bruno Chauffert; Xavier Pivot
Journal:  World J Surg Oncol       Date:  2009-02-09       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.